Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/146943| Title: | New approaches to treat Alzheimer Disease |
| Author: | Tejedor Estrada, Elisenda |
| Keywords: | Malaltia d'Alzheimer Malalties neurodegeneratives Alzheimer's disease Neurodegenerative Diseases |
| Issue Date: | Nov-2019 |
| Abstract: | A few months ago, a promising study about Alzheimer Disease (AD), a type of dementia, was published in JACC (Journal of the American College of Cardiology). Dementia affects around 50 million people worldwide and around 60-70% of them suffer AD. It is estimated that in 2050 there will be more than 115 million people diagnosed (WHO, 2019). Dementia is a disease that damages cognitive capacity interfering in daily activities. AD is a progressive dementia that worsens through time and lasts around 10-12 years, when the patient dies due to infections or other organic failure... |
| Note: | Premis Pharmanews-Fedefarma 2019 |
| URI: | http://hdl.handle.net/2445/146943 |
| Appears in Collections: | Premis Fedefarma: Concòrdia / Pharmanews (Facultat de Farmàcia i Ciències de l'Alimentació) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 3-Elisenda Tejedor Estrada-New approaches to treat Alzheimer Disease.pdf | 117.53 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
